News
3hon MSN
Playing her first singles match since stretching Aryna Sabalenka in the third round of Wimbledon , Raducanu held off the ...
Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...
6h
Investor's Business Daily on MSNWhy Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its StockReplimune stock cratered Tuesday after the Food and Drug Administration unexpectedly rejected its experimental melanoma ...
The Election Commission said on Tuesday that 26 lakh electors have shifted to different constituencies, while another seven lakh have enrolled at two places.
During the event, DDC, in the presence of the other officers, distributed loan sanction letters under Mission YUVA among 42 ...
Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...
Explore more
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Pakistan’s focus on external threats over internal reconciliation highlights its failure to assert sovereignty through ...
Security forces killed four BLA terrorists in an intelligence-based operation in Kalat, Balochistan, seizing arms and foiling ...
Naik questioned the purpose of these 19 years and what the matter was that had caused the case to drag on so long. He said that after bomb blasts took place in 2002 and 2008, all the accused were ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results